Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Donor NK cell infusion to prevent HHV6 reactivation in pediatric patients

Mercedes Gasior Kabat • 1 Sep 2020
EBMT 2020
General

Mercedes Gasior Kabat, MD, Hospital Universitario La Paz, Madrid, Spain, discusses the use of donor NK cell infusion as a strategy of immunotherapy to prevent HHV6 reactivation in pediatric patients after CD45RA-depleted transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Mercedes Gasior Kabat

2:41
T-cell depletion targeting CD45RA in HLA-mismatched HSCT
Mercedes Gasior Kabat • 22 Jun 2021
4:22
Molecular profile impacts platelet function and thrombin generation in essential thrombocythemia
Mercedes Gasior Kabat • 22 Jun 2021
3:06
Safety and outcome of prophylactic high-dose donor CD45RO+ memory T-cells after allo-HSCT
Mercedes Gasior Kabat • 31 Aug 2020

Related Videos

3:12
Addressing cardiotoxicity following CAR-T therapy and improving clinical practice
Arjun Ghosh • 25 Apr 2024
4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals